The use of metronidazole during pregnancy: A review of evidence

Current Drug Safety

Volumn 10, Issue 2, 2015, Pages 170-179

  Sheehy, Odile ^a   Santos, Fabiano ^a,b   Ferreira, Ema ^a,b   Bérard, Anick ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Birth defects; Metronidazole; Pregnancy; Preterm birth; Systematic review

Indexed keywords

METRONIDAZOLE; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CONGENITAL MALFORMATION; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; DRUG USE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; META ANALYSIS; PREGNANCY; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SYSTEMATIC REVIEW; TERATOGENICITY; TRICHOMONIASIS; VAGINITIS; ABNORMALITIES, DRUG-INDUCED; ADULT; COMPLICATION; NEWBORN; PREMATURITY; VAGINOSIS, BACTERIAL;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; INFANT, NEWBORN; METRONIDAZOLE; PREGNANCY; PREMATURE BIRTH; VAGINOSIS, BACTERIAL;

EID: 84930514219     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488631002150515124548     Document Type: Article

References (41)

1. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008; 371(9606): 75-84.
2. Giknis ML, Damjanov I. The transplacental effects of ethanol and metronidazole in Swiss Webster mice. Toxicol Lett 1983; 19(1-2): 37-42.
3. Ivanov I. Effect of the preparation trichomonacid on pregnancy in experimental animals. Akusherstvo i Ginekologiia 1969; 8(3): 241-4.
4. Tiboni GM, Marotta F, Castigliego AP. Teratogenic effects in mouse fetuses subjected to the concurrent in utero exposure to miconazole and metronidazole. Reprod Toxicol 2008; 26(3-4): 254-61.
5. Einarson A, Ho E, Koren G. Can we use metronidazole during pregnancy and breastfeeding? Putting an end to the controversy. Canadian family physician Medecin de famille canadien. 2000; 46: 1053-4.
6. Klebanoff MA, Carey JC, Hauth JC, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. New Engl J Med 2001; 345(7): 487-93.
7. Shennan A, Crawshaw S, Briley A, et al. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. BJOG : Int J Obstet Gynecol 2006; 113(1): 65-74.
8. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. New England J Med 1995; 333(26):1732-6.
9. Morales WJ, Schorr S, Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo- controlled, double-blind study. Am J Obstet Gynecol 1994; 171(2): 345-7; discussion 8-9.
10. Workowski KA, Berman S, Centers for Disease C, Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports / Centers for Disease Control. 2010; 59(RR-12): 1-110.
11. McDonald HM, O'Loughlin JA, Vigneswaran R, et al. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial. Br J Obstet Gynaecol 1997; 104(12): 1391-7.
12. Sorensen HT, Larsen H, Jensen ES, et al. Safety of metronidazole during pregnancy: a cohort study of risk of congenital abnormalities, preterm delivery and low birth weight in 124 women. J Antimicrob Chemother 1999; 44(6): 854-6.
13. Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. New Engl J Med 2000; 342(8): 534-40.
14. Goldenberg RL, Klebanoff M, Carey JC, Macpherson C. Metronidazole treatment of women with a positive fetal fibronectin test result. Am J Obstet Gynaecol 2001; 185(2): 485-6.
15. Odendaal HJ, Popov I, Schoeman J, Smith M, Grove D. Preterm labour--is bacterial vaginosis involved? South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 2002; 92(3): 231-4.
16. Okun N, Gronau KA, Hannah ME. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: Sys Rev Obstet Gynecol 2005; 105(4): 857-68.
17. Morency AM, Bujold E. The effect of second-trimester antibiotic therapy on the rate of preterm birth. J Obstet Gynaecol Canada : JOGC 2007; 29(1): 35-44.
18. Mann JR, McDermott S, Zhou L, Barnes TL, Hardin J. Treatment of trichomoniasis in pregnancy and preterm birth: an observational study. J Women's Health 2009; 18(4): 493-7.
19. Norman K, Pattinson RC, de Souza J, de Jong P, Moller G, Kirsten G. Ampicillin and metronidazole treatment in preterm labour: a multicentre, randomised controlled trial. Br J Obstet Gynaecol 1994; 101(5): 404-8.
20. Svare J, Langhoff-Roos J, Andersen LF, et al. Ampicillinmetronidazole treatment in idiopathic preterm labour: a randomised controlled multicentre trial. Br J Obstet Gynaecol 1997; 104(8): 892-7.
21. Camargo RP, Simoes JA, Cecatti JG, Alves VM, Faro S. Impact of treatment for bacterial vaginosis on prematurity among Brazilian pregnant women: a retrospective cohort study. Sao Paulo Med J 2005; 123(3): 108-12.
22. Sen A, Mahalanabis D, Mukhopadhyay S, et al. Routine use of antimicrobials by pregnant Indian women does not improve birth outcome: a randomized controlled trial. J Health Popul Nutr 2005; 23(3): 236-44.
23. Andrews WW, Sibai BM, Thom EA, et al. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol 2003; 101(5 Pt 1): 847-55.
24. Andrews WW, Goldenberg RL, Hauth JC, Cliver SP, Copper R, Conner M. Interconceptional antibiotics to prevent spontaneous preterm birth: a randomized clinical trial. Am J Obstet Gynecol 2006; 194(3): 617-23.
25. Tita AT, Cliver SP, Goepfert AR, et al. Clinical trial of interconceptional antibiotics to prevent preterm birth: subgroup analyses and possible adverse antibiotic-microbial interaction. Am J Obstet Gynecol 2007; 197(4): 367. e1-6.
26. Scott-Gray M. Metronidazole in Obstetric Practice. J Obstet Gynaecol Br Commonwealth 1964; 71: 82-5.
27. Robinson SC, Mirchandani G. Trichomonas vaginalis. V. Further observations on metronidazole (Flagyl) (including infant followup). Am J Obstet Gynecol 1965; 93(4): 502-5.
28. Rodin P, Hass G. Metronidazole and pregnancy. Br J Vener Dis 1966; 42(3): 210-2.
29. Peterson WF, Stauch JE, Ryder CD. Metronidazole in pregnancy. Am J Obstet Gynecol 1966; 94(3): 243-9.
30. Heinonen OS. SDSS. Birth defects and drugs in pregnancy. Littleton, Massachusetts: PSG Publishing 1977: 296-302.
31. Morgan I. Metronidazole treatment in pregnancy. Int J Gynaecol Obstet: the official organ of the Int Federation Gynaecol Obstet 1978;15(6):501-2.
32. Rosa FW, Baum C, Shaw M. Pregnancy outcomes after firsttrimester vaginitis drug therapy. Obstet Gynecol 1987; 69(5): 751-5.
33. Piper JM, Mitchel EF, Ray WA. Prenatal use of metronidazole and birth defects: no association. Obstet Gynecol 1993; 82(3): 348-52.
34. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995; 172(2 Pt 1): 525-9.
35. Caro-Paton T, Carvajal A, Martin de Diego I, Martin-Arias LH, Alvarez Requejo A, Rodriguez Pinilla E. Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol 1997; 44(2): 179-82.
36. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 1995; 48(8): 999-1009.
37. Czeizel AE, Rockenbauer M. A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Br J Obstet Gynaecol 1998; 105(3): 322-7.
38. Diav-Citrin O, Shechtman S, Gotteiner T, Arnon J, Ornoy A. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study. Teratology 2001; 63(5): 186-92.
39. Kazy Z, Puho E, Czeizel AE. The possible association between the combination of vaginal metronidazole and miconazole treatment and poly-syndactyly Population-based case-control teratologic study. Reprod Toxicol 2005; 20(1): 89-94.
40. Kazy Z, Puho E, Czeizel AE. Teratogenic potential of vaginal metronidazole treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 2005; 123(2): 174-8.
41. Koss CA, Baras DC, Lane SD, et al. Investigation of metronidazole use during pregnancy and adverse birth outcomes. Antimicrob Agents Chemother 2012; 56(9): 4800-5.